AAV8BP2 Serotype

Bioprocessing-optimized AAV8 variant engineered for enhanced manufacturability with improved thermal stability and production yields.

Length: 1 bp

Tropism: Liver, muscle, CNS (identical to AAV8)

Characteristics

Improved thermal stability. Higher production yields in manufacturing. Maintained wild-type AAV8 tropism profile. Enhanced scalability for clinical production. Favorable bioprocessing characteristics.

Applications

Clinical-scale liver gene therapy. Hemophilia gene therapy with improved manufacturing. Large-scale AAV production applications.

Literature References

  1. Markusic et al. (2010). High-efficiency transduction and correction of murine hemophilia B using AAV2 vectors devoid of multiple surface-exposed tyrosines. Mol Ther - Markusic 2010 AAV8BP2